Unaltered antioxidant activity of plasma in subjects at increased risk for IDDM

References

• Rabinovitch A., Suarez-Pinzon W.L., Strynadka K., Lakey J.R., Rajotte R.V. Human pancreatic islet beta-cell destruction by cytokines involves oxygen free radicals and aldehyde production. Journal of Clinical Endocrinology and Metabolism 1996; 81: 3197–3202
   PubMed Web of Science ®Google Scholar
• Horio F., Fukuda M., Katoh H., Petruzzelli M., Yano N., Rittershaus C., BonnerWeir S., Hattori M. Reactive oxygen intermediates in autoimmune islet cell destruction of the NOD mouse induced by peritoneal exudate cells (rich in macrophages) but not T cells. Diabetologia 1994; 37: 22–31
   PubMed Web of Science ®Google Scholar
• Cornelius J.G., Luttge B.G., Peck A.B. Antioxidant enzyme activities in IDD-prone and IDD-resistant mice: a comparative study. Free Radical Biology & Medicine 1993; 14: 409–420
   PubMedGoogle Scholar
• Knekt P., Alfthan G., Marniemi J., Leino A., Reunanen A., Heliövaara M., Aho K. Vitamin E and selenium in the prevention of diabetes mellitus and rheumatoid arthritis. 1998 World Congress of Oxygen Club of California. 1998, (Abstract).
   Google Scholar
• Tsai E.C., Hirsch I.B., Brunzell J.D., Chait A. Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes 1994; 43: 1010–1014
   PubMed Web of Science ®Google Scholar
• Asayama K., Uchida N., Nakane T., Hayashibe H., Dobashi K., Amemiya S., Kato K., Nakazawa S. Antioxidants in the serum of children with insulin-dependent diabetes mellitus. Free Radical Biology & Medicine 1993; 15: 597–602
   PubMed Web of Science ®Google Scholar
• Maxwell S., Holm G., Bondjers G., Wiklund O. Comparison of antioxidant activity in lipoprotein fractions from insulin-dependent diabetics and healthy controls. Atherosclerosis 1997; 129: 89–96
   PubMedGoogle Scholar
• Bingley P.J., Bonifacio E., Williams A.J.K., Genovese S., Bottazzo G.F., Gale E.A.M. Prediction of IDDM in the general population. Strategies based on combinations of autoantibody markers. Diabetes 1997; 46: 1701–1710
   PubMed Web of Science ®Google Scholar
• Ilonen J., Sjöroos M., Reijonen H., Rahko J., Kulmala P., Vähäsalo P., Knip M. HLA-DQB1 genotypes associated with IDDM risk in healthy schoolchildren positive for GAD65 and islet cell antibodies. Genetic Diversity of HLA: Functional and Medical Implications, D. Charron. EDK, Paris 1997; II: 616–618, In
   Google Scholar
• Bottazzo G.F., Florin-Christensen A., Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974; 2: 1279–1283
   PubMed Web of Science ®Google Scholar
• Lernmark A., Molenaar J.L., van Beers W.A., Yamaguchi Y., Nagataki S., Ludvigsson J., Maclaren N.K. The Fourth International Serum Exchange Workshop to standardize cytoplasmic islet cell antibodies. The Immunology and Diabetes Workshops and Participating Laboratories. Diabetologia 1991; 34: 534–535
   PubMed Web of Science ®Google Scholar
• Petersen J.S., Hejnaes K.R., Moody A., Karlsen A.E., Marshall M.O., Hoier-Madsen M., Boel E., Michelsen B.K., Dyrberg T. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 1994; 43: 459–467
   PubMed Web of Science ®Google Scholar
• Sabbah E., Kulmala P., Veijola R., Vähäsalo P., Karjalainen J., Tuomilehto-Wolf E., Akerblom H.K., Knip M. Glutamic acid decarboxylase antibodies in relation to other autoantibodies and genetic risk markers in children with newly diagnosed insulin-dependent diabetes. Childhood Diabetes in Finland Study Group. Journal of Clinical Endocrinology and Metabolism 1996; 81: 2455–2459
   PubMed Web of Science ®Google Scholar
• Palmer J.P., Asplin C.M., Clemons P., Lyen K., Tatpati O., Raghu P.K., Paquette T.L. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983; 222: 1337–1339
   PubMed Web of Science ®Google Scholar
• Bingley P.J., Colman P., Eisenbarth G.S., Jackson R.A., McCulloch D.K., Riley W.J., Gale E.A. Standardization of IVGTT to predict IDDM. Diabetes Care 1992; 15: 1313–1316
   PubMed Web of Science ®Google Scholar
• Andersen L., Dinesen B., Jorgensen P.N., Poulsen F., Roder M.E. Enzyme immunoassay for intact human insulin in serum or plasma. Clinical Chemistry 1993; 39: 578–582
   PubMed Web of Science ®Google Scholar
• Uotila J.T., Kirkkola A.L., Rorarius M., Tuimala R.J., Metsä-Ketelä T. The total peroxyl radical-trapping ability of plasma and cerebrospinal fluid in normal and preeclamptic parturients. Free Radical Biology & Medicine 1994; 16: 581–590
   PubMed Web of Science ®Google Scholar
• Wayner D.D., Burton G.W., Ingold K.U., Locke S. Quantitative measurement of the total, peroxyl radical-trapping antioxidant capability of human blood plasma by controlled peroxidation. The important contribution made by plasma proteins. FEBS Letters 1985; 187: 33–37
   PubMed Web of Science ®Google Scholar
• Wayner D.D., Burton G.W., Ingold K.U., Barclay L.R., Locke S.J. The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochimica et Biophysica Acta 1987; 924: 408–419
   PubMed Web of Science ®Google Scholar
• Miller N.J., Rice-Evans C., Davies M.J., Gopinathan V., Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clinical Science 1993; 84: 407–412
   PubMed Web of Science ®Google Scholar
• Frei B., Stocker R., Ames B.N. Antioxidant defences and lipid peroxidation in human blood plasma. Proceedings of the National Academy of Sciences USA 1988; 85: 9748–9752
   PubMed Web of Science ®Google Scholar
• Catignani G., Bieri J. Simultaneous determination of retinol and alpha-tocopherol in serum or plasma by liquid chromatography. Clinical Chemistry 1983; 29: 708–712
   PubMed Web of Science ®Google Scholar
• Ellman G. Tissue sulphydryl groups. Archives of Biochemistry and Biophysics 1959; 82: 70–77
   PubMed Web of Science ®Google Scholar
• Rocic B., Vucic M., Knezevic-Cuca J., Radica A., Pavlic-Renar I., Profozic V., Metelko Z. Total plasma antioxidants in first-degree relatives of patients with insulin-dependent diabetes. Experimental and Clinical Endocrinology and Diabetes 1997; 105: 213–217
   PubMed Web of Science ®Google Scholar
• Bingley P.J., Christie M.R., Bonifacio E., Bonfanti R., Shattock M., Fonte M.T., Bottazzo G.F., Gale E.A.M. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 1994; 43: 1304–1310
   PubMed Web of Science ®Google Scholar
• Kulmala P.K., Savola K., Petersen J.S., Vähäsalo P., Karjalainen J.K., Dyrberg T., Åkerblom H.K., Knip K., the Childhood Diabetes in Finland Study Group. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. Journal of Clinical Investigation 1998; 101: 327–333
   PubMed Web of Science ®Google Scholar
• Bingley P.J., the ICARUS Group. Interactions of age, islet cell antibodies, insulin autoantibodies and first phase insulin response in predicting risk of progression to IDDM in ICA+ relatives: The ICARUS data set. Diabetes 1996; 45: 1720–1728
   PubMedGoogle Scholar
• Halliwell B., Gutteridge J.M. The antioxidants of human extracellular fluids. Archives of Biochemistry and Biophysics 1990; 280: 1–8
   PubMed Web of Science ®Google Scholar